CONFIDENTIAL ACQUISITION OPPORTUNITY

ENDOPEEL®

Brand, Know-How & Technology Acquisition

Three Decades of Development · One Acquisition Opportunity

Three decades of clinical development, proprietary manufacturing know-how, international commercial history and technology transfer brought together in one distinctive acquisition opportunity.

≈ 30 Years 13 Historical Markets Proprietary Know-How Technology Transfer

Explore the Acquisition → Confidential Information

THE OPPORTUNITY AT A GLANCE

Endopeel® in 30 Seconds

A distinctive combination of brand equity, manufacturing expertise, clinical heritage and a structured transfer pathway.

≈ 30 Years

A long-standing clinical and technical development history.

13 Historical Markets

Experience across Europe, Eurasia, Asia, Africa and Latin America.

Proprietary Know-How

Confidential manufacturing expertise.

Technology Transfer

A structured handover to a qualified acquirer.

YOUR ACQUISITION GUIDE

Explore the Opportunity

Follow the assets, heritage and transfer pathway.

BEYOND BRAND OWNERSHIP

More Than a Trademark

Endopeel® brings together intellectual, technical, clinical and commercial assets developed over approximately three decades.

Brand Identity

The Endopeel® name and associated brand heritage.

Technical Expertise

Proprietary manufacturing know-how and supporting documentation.

Clinical & Commercial Heritage

Scientific materials, international experience and technology transfer.

Endopeel in cyan-lit marble letters above a silver-azure stardust trail in perspective

LONG-TERM ASSET DEVELOPMENT

Three Decades of Development

Approximately thirty years of accumulated development provide the context for this acquisition opportunity.

Clinical Development

A body of historical clinical experience and educational materials.

International Experience

Knowledge built through historical commercialization in multiple markets.

A Transferable Legacy

Available records and expertise to be reviewed and transferred under agreed terms.

Endopeel 30 years anniversary with a Swiss chocolate cake and silver-azure stardust

THE TECHNICAL CORE

Proprietary Manufacturing Know-How

Confidential manufacturing expertise forms a central part of the proposed acquisition package.

Process Knowledge

Manufacturing methods and operational expertise reviewed under confidentiality.

Technical Documentation

Available process records and supporting technical materials.

Controlled Handover

Scope, training and implementation requirements agreed with the acquirer.

Antique Know How book by Alain Tenenbaum and Mauro Tiziani with gilded pages and sparkling stardust

KNOWLEDGE BUILT OVER TIME

Scientific & Clinical Legacy

Historical scientific, clinical and educational materials support an informed assessment of the Endopeel® legacy.

Scientific Materials

Available publications, presentations and reference documentation for review.

Clinical Heritage

Historical clinical experience and supporting records, subject to availability and review.

Professional Education

Educational content and accumulated practitioner knowledge.

Endopeel scientific and clinical legacy illustrated by a gilded scientific book and crystal microscope amid stardust

13 HISTORICAL MARKETS

International Commercial Footprint

Historical commercialization across thirteen markets reflects an international commercial heritage.

Europe & Eurasia

Spain · Italy · Türkiye · Russia

Asia

Japan

Latin America

Mexico · Guatemala · Colombia · Peru · Bolivia · Argentina

North Africa

Algeria · Libya

Conceptual illustration

Historical markets only; this list does not imply current distribution, authorization or market access.

DISTRIBUTOR-LED EXPERIENCE

Historical Commercial Model

The historical model was primarily distributor-led, connecting local market knowledge with professional channels.

Distribution

Historical relationships and market experience assessed during due diligence.

Professional Channels

Experience serving aesthetic-medicine professionals through local distribution.

Commercial Review

Detailed records and economics are reserved for qualified confidential review.

Conceptual illustration of professional medical networks — Conceptual illustration

TRADEMARK RIGHTS & TRANSFER

Trademark Rights & Transfer Scope

The proposed acquisition includes applicable Endopeel® trademark rights within a scope to be verified during due diligence and defined in the definitive acquisition agreement.

Ownership & Registration

Review the ownership, registration status and available documentation associated with the relevant Endopeel® trademarks.

Territories & Protection

Establish the territories, classes of goods and services, and scope of protection covered by the rights under review.

Assignment & Transfer

Confirm transferability and define the rights, assignment documents and applicable formalities included in the transaction.

A Defined Scope of Rights

The final agreement will identify the trademark rights included, their territorial scope and the agreed transfer arrangements. Supporting records will be reviewed confidentially.

Explore Due Diligence

Trademark rights and regulatory authorizations are separate matters. Any future commercialization remains subject to the applicable requirements in each market.

TWO FOCUSED DIGITAL ASSETS

Strategic Digital Assets

The digital component of the proposed package is limited to the following two domains.

endopeel.com

The core Endopeel digital identity.

retensadocutaneo.com

A complementary domain within the agreed acquisition scope.

Conceptual illustration of strategic digital assets — Conceptual illustration

A COHERENT ACQUISITION PACKAGE

Assets Included

An integrated package of rights, knowledge, documentation and digital assets, subject to verification and definitive agreement.

Brand & Rights

Endopeel® brand and applicable trademark rights.

Manufacturing Know-How

Confidential technical expertise and available supporting documentation.

Scientific & Clinical Materials

Available historical scientific, clinical and educational records.

Digital Assets

endopeel.com and retensadocutaneo.com only.

Commercial Heritage

Available historical commercial documentation.

Technology Transfer

A handover programme to be agreed.

Conceptual illustration of a confidential asset portfolio — Conceptual illustration

FROM OWNERSHIP TO UNDERSTANDING

Technology Transfer

A structured technology transfer can accompany the acquisition, with scope and responsibilities defined together.

01 · Assessment

Review available materials, requirements and proposed transfer scope.

02 · Knowledge Transfer

Organize documentation, technical sessions and agreed training.

03 · Handover

Define milestones, acceptance criteria and implementation responsibilities.

Endopeel technology transfer illustrated by two hands passing a gilded book amid luminous stardust — ENDOPEEL® · TECHNOLOGY TRANSFER

FOR QUALIFIED STRATEGIC ACQUIRERS

Acquisition Opportunity

An opportunity for a qualified group seeking a distinctive aesthetic-medicine brand, technical heritage and a defined transfer pathway.

Transaction

An asset and technology-transfer opportunity. Styling Cosmetics AG is outside the transaction.

Terms

USD 2,500,000 for the complete package. Structure and scope are discussed confidentially.

Future Commercialization

Future commercialization depends on applicable regulatory requirements in each market at the relevant time. Historical activity does not establish current authorization.

Conceptual illustration

A STRUCTURED PRIVATE REVIEW

Confidential Due Diligence

Qualified parties can request a confidential discussion and review available information under an appropriate confidentiality framework.

01 · Introduction

Present your organization, strategic interest and proposed scope.

02 · Confidentiality

Agree the confidentiality framework before access to sensitive information.

03 · Document Review

Assess rights, technical materials, commercial history and regulatory requirements.

04 · Terms & Transfer

Discuss transaction terms and the proposed handover programme.

Request a Confidential Discussion →

CLEAR ANSWERS

Frequently Asked Questions

Key points for an initial assessment.

What is being acquired?

A proposed package combining the Endopeel® brand, relevant rights, manufacturing know-how, available documentation, two digital assets and an agreed technology transfer.

Which domains are included?

Only endopeel.com and retensadocutaneo.com.

Is a company being sold?

This is an asset acquisition opportunity. Styling Cosmetics AG is outside the transaction.

What is the price?

USD 2,500,000 for the complete package. Terms are discussed with qualified parties confidentially.

Can the product be commercialized immediately?

No immediate market access is implied. Future commercialization requires assessment of applicable regulatory requirements.

How are sensitive materials shared?

Through qualified due diligence under an agreed confidentiality framework.

THE NEXT CHAPTER

Begin a Confidential Conversation

Explore the Endopeel® brand, know-how and technology acquisition with a focused, confidential discussion.

USD 2,500,000

For the complete package.

Introduce your organization and strategic interest to begin the qualification process.

Request a Confidential Discussion →